In conclusion, identifying the viral trigger of IL-10 release (viral genotype) and the cellular source and downstream pathways of IL-10 (endotype) in SARS-CoV-2 infection will reveal whether increased blood levels of this cytokine are a bystander or driver of disease in the different phases of COVID-19 (clinical phenotype). This evidence concerns the gene IL10 and COVID-19.